发明名称 INFLAMMATORY DISEASE-TREATING AGENT
摘要 PROBLEM TO BE SOLVED: To provide an elucidation of a target gene of a PGI2-PPARδtransmission system and a new inflammatory disease-treating agent by taking the PGI2-PPARδtransmission system as the target. SOLUTION: This target of the PG (prostaglandin) I2-PPAR (peroxisome proliferator-activated receptor)δtransmission system is found to be an IL (interleukin)-13 gene by a microarray analysis. The association of a PGI2-PPARδ-IL-13 pathway with cellular adhesion is examined, and a fact that the production of the IL-13 mediated by the PPARδinhibits the adhesion of monocytes with endothelium cells markedly is elucidated. The association between the PGI2-PPARδ-IL-13 pathway and COX (cyclooxygenase)-2 is examined, and it is found that the IL-13 production mediated by PGI2/PPARδinhibits the expression of the COX-2. It is known that the monocyte-endothelium cell adhesion and COX-2 are related to the inflammation. Therefore, it is possible to use a cell adhesion inhibitor or COX-2 inhibitor by taking the PGI2-PPARδ-IL-13 pathway as the target can be utilized as an anti-inflammatory agent. COPYRIGHT: (C)2005,JPO&NCIPI
申请公布号 JP2005120069(A) 申请公布日期 2005.05.12
申请号 JP20040049299 申请日期 2004.02.25
申请人 ANGES MG INC 发明人 HATAE TOSHIHISA;YOKOYAMA CHIEISHI;TANABE TADASHI
分类号 A61K45/00;A61K31/00;A61K31/557;A61K31/5585;A61K31/7088;A61K38/00;A61K48/00;A61P29/00;C12N9/90;(IPC1-7):A61K45/00;A61K31/558;A61K31/708 主分类号 A61K45/00
代理机构 代理人
主权项
地址